Publicaciones en colaboración con investigadoras/es de Hospital Universitario de Donostia (47)

2019

  1. Autoamputation of a polypoid carcinoma of the rectum

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 8, pp. 486-487

  2. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies

    Helicobacter, Vol. 24, Núm. 1

  3. Short article: Hormone therapy for severe gastrointestinal bleeding due to multiple angiodysplastic lesions

    European Journal of Gastroenterology and Hepatology, Vol. 31, Núm. 3, pp. 312-315

2017

  1. Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance

    World Journal of Gastroenterology, Vol. 23, Núm. 18, pp. 3367-3373

  2. Triple synchronous gastric tumors: A rare combination diffuse adenocarcinoma, B-cell MALT lymphoma and large cell neuroendocrine carcinoma

    Gastroenterologia y Hepatologia, Vol. 40, Núm. 10, pp. 675-677

2016

  1. Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance

    Helicobacter, Vol. 21, Núm. 1, pp. 29-34

  2. Effect of pravastatin on the survival of patients with advanced gastric cancer

    Oncotarget, Vol. 7, Núm. 4, pp. 4379-4384

  3. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: Results of the Spanish follow-up multicenter study

    Journal of Gastroenterology and Hepatology (Australia), Vol. 31, Núm. 5, pp. 953-958

2015

  1. Colorectal cancer in a second round after a negative faecal immunochemical test

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 7, pp. 813-818

2014

  1. Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions

    European Journal of Gastroenterology and Hepatology, Vol. 26, Núm. 12, pp. 1380-1384

  2. Effect of oral anticoagulants on the outcome of faecal immunochemical test

    British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337

2013

  1. Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test

    Mayo Clinic Proceedings

  2. Evaluation of Alpha 1-Antitrypsin and the Levels of mRNA Expression of Matrix Metalloproteinase 7, Urokinase Type Plasminogen Activator Receptor and COX-2 for the Diagnosis of Colorectal Cancer

    PLoS ONE, Vol. 8, Núm. 1

  3. Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori

    Clinical Microbiology and Infection, Vol. 19, Núm. 4, pp. 379-383

2011

  1. Características clínicas y evolutivas de una familia con hemocromatosis hereditaria tipo 1

    Gaceta Medica de Bilbao, Vol. 108, Núm. 2, pp. 42-48

  2. Clinical patterns and outcomes of ischaemic colitis: Results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)

    Scandinavian Journal of Gastroenterology, Vol. 46, Núm. 2, pp. 236-246

2010

  1. Colorectal cancer prognosis twenty years later

    World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867

  2. Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

    Digestive and Liver Disease, Vol. 42, Núm. 4, pp. 287-290

  3. Niveles plasmóticos de la vitamina B12 y ácido fólicoenpacientes con hepatopatía crónica

    Gastroenterologia y Hepatologia, Vol. 33, Núm. 4, pp. 280-287

2009

  1. Características clinicopatológicas y supervivencia de los pacientes con cáncer de esófago. Resultados de 200 casos consecutivos

    Medicina Clinica, Vol. 133, Núm. 18, pp. 689-693